Novo's Wegovy supply rebound on track for later this year as demand stays strong
Ozempic Maker Novo Rises After First Stock Split in a Decade - BNN Bloomberg
They took blockbuster drugs for weight loss and diabetes. Now their stomachs are paralyzed
Blockbuster weight-loss drug Ozempic is a boon for Novo Nordisk (NVO)
Novo Nordisk Boosts Guidance as Sales of Weight-Loss Drug Wegovy Soar
Ozempic's maker was briefly Europe's biggest market cap stock
Novo Nordisk (NVO) to Report Q3 Earnings: What's in the Cards?
Top Performing Drug – Ozempic (September Edition)
Novo Nordisk, Up 25X In 20 Years, Can Repeat: Focus On Semaglutide (NYSE:NVO)
Top Performing Drug – Ozempic (September Edition)
S&P 500 Gains and Losses Today: Index Moves Higher Ahead of Key Inflation Data